Lionel Zuckier, MD, MBA, Joins Columbia Radiology
We are very pleased to announce that Lionel Zuckier, MD, MBA has joined the Department of Radiology at Columbia University Irving Medical Center as professor of radiology. Zuckier will serve as director of theranostics within the Division of Nuclear Medicine and will lead efforts to develop clinical and research protocols in this promising area of therapy.
A highly accomplished physician-scientist, Zuckier previously served as division head of nuclear medicine at Montefiore Medical Center, where he oversaw the introduction of the prostate cancer theranostic program and was involved in phase I trials of a novel peptide imaging agent. His group also applied its expertise in lung imaging of pulmonary embolism to suggest revised protocols during the COVID-19 pandemic which were adopted nationally and internationally. He has also served as division head of nuclear medicine at the University of Ottawa, where he collaborated closely with thrombosis researchers focused on lung imaging of pulmonary embolism and with the prominent evidence-based medicine group at the Ottawa Hospital Research Institute.
“We are very fortunate to have Dr. Zuckier join our team at Columbia Radiology and NewYork-Presbyterian,” said Ajay Gupta, MD, MS, professor of radiology and chair of the Department of Radiology at the Columbia University Vagelos College of Physicians and Surgeons. “His leadership in the rapidly evolving field of theranostics will be invaluable as we continue to expand our clinical and research initiatives. Dr. Zuckier's proven track record in nuclear medicine, along with his many contributions to personalized cancer therapies and imaging techniques, will significantly enhance our mission to provide cutting-edge care to the patients we serve."
The author of more than 120 publications, Zuckier lectures and publishes widely in all facets of nuclear medicine. He has guest edited several issues of Seminars in Nuclear Medicine and the Journal of Medical Imaging and Radiation Sciences and has coedited Nuclear Medicine Board Review, a trainee review book, and Clinical Nuclear Medicine, a textbook of general nuclear medicine and molecular imaging. He serves as chair of the General Clinical Nuclear Medicine Council of the Society of Nuclear Medicine and Molecular Imaging and is actively involved in several guidelines consensus committees. He also maintains an organizational role within the Targeted Alpha Therapy (TAT) group.
Zuckier is a graduate of the Albert Einstein College of Medicine, where he also completed residencies in nuclear medicine and diagnostic radiology and pursued a National Institutes of Health (NIH) physician scientist award related to targeting of monoclonal antibodies in the laboratory of Dr. Matthew Scharff, a renowned B-cell immunologist. He also holds a Master of Business Administration from the University of Massachusetts, tailored towards physician executives.